Background illustration for clinical trials search

Cardiovascular Clinical Trials

Browse 3,486 Cardiovascular clinical trials enrolling across the United States and Canada. 275 people applied to Cardiovascular studies last month. Search by city or state to find one near you.

Filter
1

Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)

for
Pulmonary Hypertension
Location: Paramus NJ
Sponsor: Valley Health System

Sex: All

Age: 18+

Code: NCT07837830

Early Phase 1, Recruiting

Red Light Treatment in Peripheral Artery Disease

for
Peripheral Artery Disease, Claudication, Intermittent,
Location: Milwaukee WI
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT03203239

Recruiting

Mavacamten Pregnancy Surveillance Program

for
Breastfeeding, Hypertrophic Cardiomyopathy, Pregnancy Related
Location: Wilmington NC
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 15+

Code: NCT05939700

Recruiting

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

for
Psychological Stress, Hypertension, Renal
Location: Augusta GA
Sponsor: Augusta University

Sex: All

Age: 18 - 50

Code: NCT02432339

Phase 1, Phase 2, Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health

for
Coronary Artery Disease
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 30 - 70+

Code: NCT07087431

Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Fall River MA, Flushing NY, New York NY, Albany NY,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Optimal Pacing Rate for Cardiac Resynchronization Therapy

for
Atrial Fibrillation, Persistent
Location: Clinton MD, Washington DC, Fairfax VA
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06445439

Recruiting

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

for
Pulmonary Embolism
Location: York PA
Sponsor: WellSpan Health

Sex: All

Age: 18+

Code: NCT05050617

Recruiting

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT04661137

Phase 2, Recruiting

MBA Early Feasibility Study

for
Thoracic Aortic Aneurysm, Penetrating Aortic Ulcers (PAUs),
Location: Cleveland OH, Plano TX, Los Angeles CA
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT07564375

Recruiting

Making Connections Thru Music

for
Dementia, Alzheimer Disease, Vascular Dementia
Location: Winchester MA
Sponsor: Hopeful Aging

Sex: All

Age: 18 - 70+

Code: NCT06079216

Recruiting

A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)

for
Hereditary Hemorrhagic Telangiectasia
Location: Gainesville FL, Indianapolis IN, Chicago IL,
Sponsor: Vaderis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07743671

Phase 3, Recruiting

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Ottawa IL, Bloomington IL, Decatur IL, Peru IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06948084

Phase 2, Recruiting

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

for
Myeloma Multiple
Location: Anchorage AK
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18+

Code: NCT07085728

Phase 2, Recruiting

A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

for
Coarctation of Aorta, High Blood Pressure
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06150560

Phase 3, Recruiting

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

for
Follicular Lymphoma,
Location: Louisville KY
Sponsor: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

Sex: All

Age: 18+

Code: NCT05003141

Phase 1, Recruiting

Magneto-rheology to Lower Blood Pressure

for
Hypertension
Location: Philadelphia PA
Sponsor: Cardiovascular Therapy LLC

Sex: All

Age: 18 - 70+

Code: NCT03783117

Recruiting

A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Rochester MN
Sponsor: Vyriad, Inc.

Sex: All

Age: 18+

Code: NCT07802717

Phase 1, Recruiting

Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

for
Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 21+

Code: NCT07527117

Recruiting

What is cardiovascular disease?

Cardiovascular disease is the group of conditions that affect the heart and blood vessels, and together they are the leading cause of death in the United States. The most common is coronary artery disease, in which cholesterol filled plaque narrows the arteries that feed the heart and can cause a heart attack. Others include heart failure, where the heart cannot pump well enough; rhythm problems such as atrial fibrillation; stroke, when blood flow to the brain is blocked; and disease of the heart valves and peripheral arteries. High blood pressure, high cholesterol, diabetes, smoking, obesity, and inactivity drive most of it.

Much of cardiovascular disease can be prevented or slowed, and nearly every tool doctors use came from large trials that measured real heart attacks, strokes, and deaths rather than lab numbers. One frontier is lipoprotein(a), an inherited cholesterol like particle that is high in about 1 in 5 people and cannot be lowered by diet, exercise, or any approved medicine; large outcome trials of drugs that target it are under way.

Types of cardiovascular clinical trials

Who can participate in cardiovascular clinical trials?

How is cardiovascular disease prevented?

Types of cardiovascular disease, and where to find their trials

How to enroll in a cardiovascular clinical trial